[Enteropathic amyloidosis: clinical features, place among other forms of amyloidosis].
Miagkova
L P
LP
D000682:Amyloid / Q000096:biosynthesis* / Q000187:drug effects; D000686:Amyloidosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003078:Colchicine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D007410:Intestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000473:pathology; D011379:Prognosis
D000682:Amyloid; D006074:Gout Suppressants; D003078:Colchicine